Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
03/07/2026 14:33
BRIEF-Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026 July 3 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS:
BLISS GVS PHARMA - APPOINTS RAHUL ADAKMOL AS CEO EFFECTIVE JULY 15, 2026
BLISS GVS PHARMA - NARSIMHA SHIBROOR KAMATH RESIGNS AS CEO EFFECTIVE JULY 14, 2026
Source text: ID:nBSE2FsYwW
Further company coverage: BLIS.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees